GJC1

gene
On this page

Also known as CX45

Summary

GJC1 (gap junction protein gamma 1, HGNC:4280) is a protein-coding gene on chromosome 17q21.31, encoding Gap junction gamma-1 protein (P36383). Structural component of the gap junction, a specialized intercellular structure consisting of a cluster of closely packed pairs of transmembrane channels, the connexons, that allow passage of small molecules and electrical signals between neighboring cells.

This gene is a member of the connexin gene family. The encoded protein is a component of gap junctions, which are composed of arrays of intercellular channels that provide a route for the diffusion of low molecular weight materials from cell to cell. Alternatively spliced transcript variants encoding the same isoform have been described.

Source: NCBI Gene 10052 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 42 total
  • MANE Select transcript: NM_005497

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:4280
Approved symbolGJC1
Namegap junction protein gamma 1
Location17q21.31
Locus typegene with protein product
StatusApproved
AliasesCX45
Ensembl geneENSG00000182963
Ensembl biotypeprotein_coding
OMIM608655
Entrez10052

Gene structure

Transcript identifiers

Ensembl transcripts: 20 — 20 protein_coding

ENST00000330514, ENST00000586267, ENST00000586347, ENST00000587113, ENST00000587239, ENST00000590758, ENST00000591424, ENST00000592524, ENST00000907279, ENST00000907280, ENST00000907281, ENST00000907282, ENST00000907284, ENST00000920109, ENST00000920110, ENST00000920111, ENST00000920112, ENST00000920113, ENST00000964185, ENST00000964186

RefSeq mRNA: 2 — MANE Select: NM_005497 NM_001080383, NM_005497

CCDS: CCDS11487

Canonical transcript exons

ENST00000592524 — 3 exons

ExonStartEnd
ENSE000013113424479844844805837
ENSE000015156994480739444807469
ENSE000015157004483006244830287

Expression profiles

Bgee: expression breadth ubiquitous, 229 present calls, max score 94.91.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.5710 / max 74.8246, expressed in 1130 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1664003.57101130
1664011.4925542

Top tissues by expression

275 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cauda epididymisUBERON:000436094.91gold quality
seminal vesicleUBERON:000099893.81gold quality
cartilage tissueUBERON:000241891.69gold quality
secondary oocyteCL:000065591.19gold quality
adult organismUBERON:000702390.90gold quality
visceral pleuraUBERON:000240190.25gold quality
saphenous veinUBERON:000731889.84gold quality
placentaUBERON:000198788.76gold quality
ventricular zoneUBERON:000305388.53gold quality
colonic epitheliumUBERON:000039788.50gold quality
myometriumUBERON:000129687.89gold quality
cortical plateUBERON:000534387.76gold quality
urethraUBERON:000005787.60gold quality
ganglionic eminenceUBERON:000402387.51gold quality
parietal pleuraUBERON:000240087.50gold quality
oocyteCL:000002387.31gold quality
muscle layer of sigmoid colonUBERON:003580586.89gold quality
pleuraUBERON:000097786.81gold quality
body of uterusUBERON:000985386.18gold quality
stromal cell of endometriumCL:000225586.11gold quality
smooth muscle tissueUBERON:000113586.07gold quality
deciduaUBERON:000245085.97gold quality
lower lobe of lungUBERON:000894985.84gold quality
sural nerveUBERON:001548884.88gold quality
heart right ventricleUBERON:000208084.23gold quality
tendon of biceps brachiiUBERON:000818883.40gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099182.89gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047382.86gold quality
apex of heartUBERON:000209882.42gold quality
uterusUBERON:000099581.80gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-MTAB-7249yes39.46
E-ANND-3yes13.63
E-MTAB-6678yes11.48
E-GEOD-111727no173.78

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

180 targeting GJC1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-3163100.0077.238605
HSA-MIR-200B-3P100.0073.312693
HSA-MIR-200C-3P100.0073.352685
HSA-MIR-429100.0073.442698
HSA-MIR-1252-5P100.0069.802774
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-4425100.0067.591049
HSA-MIR-126-5P100.0072.713180
HSA-MIR-450099.9972.722367
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-4789-3P99.9970.752484
HSA-MIR-428299.9975.366408
HSA-MIR-150-5P99.9966.691976
HSA-MIR-453499.9966.581907
HSA-MIR-548N99.9871.944170
HSA-MIR-477599.9875.006394
HSA-LET-7A-5P99.9872.291790
HSA-LET-7C-5P99.9872.291790
HSA-LET-7E-5P99.9872.291790
HSA-LET-7F-5P99.9872.561784
HSA-MIR-98-5P99.9872.331787
HSA-LET-7B-5P99.9872.311790
HSA-LET-7G-5P99.9872.371784
HSA-LET-7I-5P99.9872.371788
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-1213699.9872.815713
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-590-3P99.9674.346478

Literature-anchored findings (GeneRIF, showing 25)

  • Data suggest that the dynamic changes of connexins 43, 40 and 45 during mouse cardiac development appear to be mirrored in the human. (PMID:12064615)
  • abnormal expression of connexin43 and connexin45 in nasopharynx tissues may be associated with cancerization and squamatization of human nasopharynx tissue (PMID:12452056)
  • mRNA levels of connexins in different sizes of luteinized normal and hyperstimulated follicles. (PMID:14667880)
  • The staining patterns for Cx45 rather were typified by granular cytoplasmic staining. (PMID:14766937)
  • Cx45 has a complex binding interaction with zonula occludens-1 (ZO-1) that involves either an extended carboxyl terminal domain or two distinct binding sites. (PMID:16463142)
  • Cx40/Cx45 junctions demonstrate electrical signal transfer asymmetry that can be modulated between unidirectional and bidirectional by small changes in the difference between holding potentials of the coupled cells. (PMID:17189315)
  • a cross-talk between CFTR and a variety of gap junction channels. Cytoskeletal scaffolding proteins and/or other intermediate cytoplasmic proteins are likely to play a role in CFTR-connexins interaction. (PMID:17546509)
  • Studies indicate that 21 different Cxs have been detected and they are generally named according to their approximate molecular mass in Kda, e.g. Cx32, Cx43 and Cx45. (PMID:19883623)
  • Results show that Cx40, Cx37, Cx43 and Cx45 were expressed within the glomeruli. (PMID:20530971)
  • connexin genes Gjd2 coding for mCx36, Gjc1 coding for mCx45 and Gja10 coding for mCx57 in the mouse, a subset of 4 connexin genes, including the unique GJA9 (Cx59) and GJA10 (Cx62), could be detected at least as transcript isoforms in the human retina. (PMID:20979653)
  • Our data suggest that GJA7 alterations have no or low genetic relevance in nonsyndromic hearing loss in populatins from Turkey, South Africa, United Kingdom, United States, and China. (PMID:21254920)
  • DNA hypermethylation of the promoter region of GJC1, encoding connexin45, is an important mechanism in silencing gene expression in colorectal cancer. (PMID:21406965)
  • Study shows that fusion of a V5/6-His tag (hexa moiety M r = 0.93 kDa) to the CT segment of Cx40, Cx43 and Cx45 does not prevent the cells from forming channels. (PMID:21424225)
  • Gap junctional intercellular communication in human bladder smooth muscle cells and suburothelial myofibroblastsdepend of Cx43 rather than on Cx45. (PMID:21674053)
  • Results found that the expression of Cx26 and Cx45 had no prognostic value but Cx43 was upregulated in tumour epithelia and membrane Cx43 expression was associated with short overall survival time. (PMID:24788723)
  • Connexin45 has much more rapid gating kinetics than connexin43 (PMID:25401181)
  • Human deltoid muscle biopsies of 5 Chilean dysferlinopathy patients exhibited the presence of muscular connexins (Cx40.1, Cx43 and Cx45). (PMID:27229680)
  • our data highlighted the critical role of CX45 in reprogramming and may increase the cell division rate and result in an accelerated kinetics of iPSCs production. (PMID:28352086)
  • human Cx40/Cx45 and Cx43/Cx45 heterotypic gap junctions were investigated by recombinant expression in GJ deficient cells. (PMID:28760564)
  • Observations involving both N- and C-domains of CaM to interact with the Cx45 peptide differ from the embraced interaction with Cx50 from another connexin family (PMID:28963343)
  • The HG-stimulated proliferative capacity was abolished upon decreasing O-GlcNAcylation, which could be reversed gradually by the simultaneous overexpression of APA1 and GJC1. Therefore, GJC1 could be a potential target for preventing liver cancer in patients with diabetes. (PMID:30078215)
  • Cx40 or Cx45 Gap junctions showed little changes in the extent of voltage-dependent-gating, but in both cases with a faster deactivation kinetics at high temperatures. (PMID:30594539)
  • Identification of Cx45 as a Major Component of GJs in HeLa Cells. (PMID:33003547)
  • Connexin45 (GJC1) loss-of-function mutation contributes to familial atrial fibrillation and conduction disease. (PMID:33429106)
  • The role of the Cx43/Cx45 gap junction voltage gating on wave propagation and arrhythmogenic activity in cardiac tissue. (PMID:37684404)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusGjc1ENSMUSG00000034520
rattus_norvegicusGjc1ENSRNOG00000048838

Paralogs (20): GJA8 (ENSG00000121634), GJB6 (ENSG00000121742), GJA3 (ENSG00000121743), GJA9 (ENSG00000131233), GJA10 (ENSG00000135355), GJA1 (ENSG00000152661), GJD2 (ENSG00000159248), GJB7 (ENSG00000164411), GJB2 (ENSG00000165474), GJB1 (ENSG00000169562), GJC3 (ENSG00000176402), GJD4 (ENSG00000177291), GJD3 (ENSG00000183153), GJA4 (ENSG00000187513), GJB3 (ENSG00000188910), GJB5 (ENSG00000189280), GJB4 (ENSG00000189433), GJC2 (ENSG00000198835), GJE1 (ENSG00000203733), GJA5 (ENSG00000265107)

Protein

Protein identifiers

Gap junction gamma-1 proteinP36383 (reviewed: P36383)

Alternative names: Connexin-45, Gap junction alpha-7 protein

All UniProt accessions (7): P36383, A0A654IDC0, K7EM78, K7ENT9, K7EQ14, K7ERH3, Q5H9P2

UniProt curated annotations — full annotation on UniProt →

Function. Structural component of the gap junction, a specialized intercellular structure consisting of a cluster of closely packed pairs of transmembrane channels, the connexons, that allow passage of small molecules and electrical signals between neighboring cells. Forms homotypic and heterotypic channels gated by transjunctional voltage. Involved in intercellular innate immune signaling. Mediates translocation of 2’,3’-cGAMP and 2’,5’-oligoadenylates (2-5A) second messengers from virus-infected cells to macrophages and uninfected neighboring cells to propagate and amplify the antiviral immune response.

Subunit / interactions. A connexon/hemichannel is composed of a hexamer of connexins. Forms functional homotypic gap junctions consisting of identical hemichannels both made of the same connexin type as well as heterotypic gap junctions consisting of two different hemichannels, each containing a different type of connexin. Assembles with GJA1 to form heterotypic gap junction channels. Interacts with CNST.

Subcellular location. Cell membrane. Cell junction. Gap junction.

Similarity. Belongs to the connexin family. Gamma-type subfamily.

RefSeq proteins (2): NP_001073852, NP_005488* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000500ConnexinFamily
IPR002265Connexin45Family
IPR013092Connexin_NDomain
IPR017990Connexin_CSConserved_site
IPR019570Connexin_CCCDomain
IPR038359Connexin_N_sfHomologous_superfamily

Pfam: PF00029

Catalyzed reactions (Rhea), 2 shown:

  • 2’,3’-cGAMP(out) = 2’,3’-cGAMP(in) (RHEA:66320)
  • 5’-triphosphoadenylyl-(2’->5’)-adenylyl-(2’->5’)-adenosine(out) = 5’-triphosphoadenylyl-(2’->5’)-adenylyl-(2’->5’)-adenosine(in) (RHEA:85019)

UniProt features (16 total): topological domain 5, transmembrane region 4, region of interest 2, compositionally biased region 2, sequence conflict 2, chain 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
3SHWX-RAY DIFFRACTION2.9

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P36383-F169.520.28

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-112303Electric Transmission Across Gap Junctions
R-HSA-190861Gap junction assembly

MSigDB gene sets: 229 (showing top): GOBP_MUSCLE_TISSUE_DEVELOPMENT, GOBP_CIRCULATORY_SYSTEM_PROCESS, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, REACTOME_MEMBRANE_TRAFFICKING, GOBP_CELL_CELL_SIGNALING, BROWNE_HCMV_INFECTION_48HR_DN, PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP, IRF7_01, GOBP_CELL_JUNCTION_ORGANIZATION, GOBP_MUSCLE_CONTRACTION, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2, GOBP_CELL_COMMUNICATION_INVOLVED_IN_CARDIAC_CONDUCTION, GOBP_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS, GOBP_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING, GOBP_CELL_CELL_SIGNALING_INVOLVED_IN_CARDIAC_CONDUCTION

GO Biological Process (16): vasculogenesis (GO:0001570), muscle contraction (GO:0006936), cell-cell junction assembly (GO:0007043), cell-cell signaling (GO:0007267), chemical synaptic transmission (GO:0007268), visual perception (GO:0007601), gap junction assembly (GO:0016264), cell development (GO:0048468), cardiac muscle tissue development (GO:0048738), atrial cardiac muscle cell action potential (GO:0086014), SA node cell to atrial cardiac muscle cell communication by electrical coupling (GO:0086021), AV node cell to bundle of His cell communication by electrical coupling (GO:0086053), cell communication (GO:0007154), heart development (GO:0007507), monoatomic ion transmembrane transport (GO:0034220), transmembrane transport (GO:0055085)

GO Molecular Function (5): monoatomic ion channel activity (GO:0005216), gap junction channel activity (GO:0005243), gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling (GO:0086020), gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling (GO:0086077), protein binding (GO:0005515)

GO Cellular Component (10): nucleoplasm (GO:0005654), endoplasmic reticulum (GO:0005783), endoplasmic reticulum membrane (GO:0005789), plasma membrane (GO:0005886), gap junction (GO:0005921), connexin complex (GO:0005922), intercalated disc (GO:0014704), synapse (GO:0045202), membrane (GO:0016020), anchoring junction (GO:0070161)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
Transmission across Electrical Synapses1
Gap junction trafficking1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cell differentiation2
cell communication by electrical coupling involved in cardiac conduction2
cellular process2
gap junction channel activity involved in cardiac conduction electrical coupling2
cellular anatomical structure2
cell junction2
blood vessel morphogenesis1
muscle system process1
cell junction assembly1
cell-cell junction organization1
cell communication1
signaling1
anterograde trans-synaptic signaling1
sensory perception of light stimulus1
cell-cell junction assembly1
anatomical structure development1
cellular developmental process1
heart development1
striated muscle tissue development1
cardiac muscle cell action potential involved in contraction1
atrial cardiac muscle cell to AV node cell signaling1
SA node cell to atrial cardiac muscle cell communication1
AV node cell to bundle of His cell communication1
animal organ development1
circulatory system development1
monoatomic ion transport1
transmembrane transport1
transport1
monoatomic ion transmembrane transporter activity1
channel activity1
wide pore channel activity1
SA node cell to atrial cardiac muscle cell communication by electrical coupling1
AV node cell to bundle of His cell communication by electrical coupling1
binding1
nuclear lumen1
cytoplasm1
endomembrane system1
intracellular membrane-bounded organelle1
organelle membrane1
nuclear outer membrane-endoplasmic reticulum membrane network1

Protein interactions and networks

STRING

586 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
GJC1GJA1P17302984
GJC1GJA5P36382983
GJC1GJB6O95452895
GJC1TJP1Q07157892
GJC1GJE1A6NN92861
GJC1GJA4P35212836
GJC1HCN4Q9Y3Q4823
GJC1GJD2Q9UKL4775
GJC1CNSTQ6PJW8730
GJC1MIPP30301687
GJC1TJP3O95049651
GJC1GJB2P29033641
GJC1NKX2-5P52952624
GJC1PANX1Q96RD7601
GJC1PKP2Q99959582

IntAct

154 interactions, top by confidence:

ABTypeScore
GJC1MEOX2psi-mi:“MI:0915”(physical association)0.560
GJC1SLC66A1psi-mi:“MI:0915”(physical association)0.560
APOL3GJC1psi-mi:“MI:0915”(physical association)0.560
GJC1TMEM86Apsi-mi:“MI:0915”(physical association)0.560
ADGRG5KLRG2psi-mi:“MI:0914”(association)0.530
ZACNGPAA1psi-mi:“MI:0914”(association)0.530
PTGIRTMEM63Apsi-mi:“MI:0914”(association)0.530
SLC22A16APBA3psi-mi:“MI:0914”(association)0.530
NRASESYT2psi-mi:“MI:2364”(proximity)0.480
GJC1HTRA3psi-mi:“MI:0407”(direct interaction)0.440
GJC1PDZD2psi-mi:“MI:0407”(direct interaction)0.440
GJC1LNX2psi-mi:“MI:0407”(direct interaction)0.440
GJC1GORASP2psi-mi:“MI:0407”(direct interaction)0.440
GJC1TJP1psi-mi:“MI:0407”(direct interaction)0.440
GJC1HTRA1psi-mi:“MI:0407”(direct interaction)0.440
GJC1TJP2psi-mi:“MI:0407”(direct interaction)0.440
GJC1PARD3Bpsi-mi:“MI:0407”(direct interaction)0.440
GJC1HTRA4psi-mi:“MI:0407”(direct interaction)0.440
GJC1PARD3psi-mi:“MI:0407”(direct interaction)0.440
GJC1GORASP1psi-mi:“MI:0407”(direct interaction)0.440
GJC1APBA1psi-mi:“MI:0407”(direct interaction)0.440
GJC1TJP3psi-mi:“MI:0407”(direct interaction)0.440
GJC1GRIP2psi-mi:“MI:0407”(direct interaction)0.440
GJC1GRID2IPpsi-mi:“MI:0407”(direct interaction)0.440
GJC1HTRA2psi-mi:“MI:0407”(direct interaction)0.440
GJC1NHERF4psi-mi:“MI:0407”(direct interaction)0.440
GJC1DVL3psi-mi:“MI:0407”(direct interaction)0.440
GJC1SCRIBpsi-mi:“MI:0407”(direct interaction)0.440
GJC1TIAM2psi-mi:“MI:0407”(direct interaction)0.440

BioGRID (68): GJC1 (Affinity Capture-MS), EXTL2 (Affinity Capture-MS), GJC1 (Affinity Capture-MS), GJC1 (Affinity Capture-MS), GJC1 (Reconstituted Complex), UBQLN4 (Affinity Capture-Western), PSMD2 (Affinity Capture-Western), GJC1 (Affinity Capture-MS), GJC1 (Affinity Capture-MS), GJC1 (Affinity Capture-MS), GJC1 (Affinity Capture-MS), GJC1 (Affinity Capture-MS), GJC1 (Affinity Capture-MS), GJC1 (Affinity Capture-MS), GJC1 (Affinity Capture-MS)

ESM2 similar proteins: A0A0U1QT59, A2VEY9, A8X9H4, D3KZG3, O35412, O35607, O57474, O61366, O93383, P18861, P29415, P34535, P36383, P43322, P49414, P50605, P60571, P91682, Q02297, Q03345, Q05199, Q11069, Q13873, Q14693, Q2THW7, Q2THW9, Q2THX1, Q5R838, Q5RJX2, Q5YCC7, Q64448, Q69ZW3, Q6DR98, Q6H1V1, Q6IMP4, Q6TYA8, Q7TQ69, Q7Z5M5, Q86B91, Q8INR6

Diamond homologs: A2VE67, A4GG66, A4GVD1, A4IFL1, A6XKM2, O18968, O54851, O57474, O70610, O75712, O93533, O95377, O95452, P08033, P08034, P08050, P08983, P14154, P16863, P16864, P17302, P18246, P18860, P18861, P21994, P23242, P25305, P28228, P28229, P28230, P28231, P28232, P28233, P28234, P28235, P28236, P29033, P29414, P29415, P33725

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 119 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Ras activation upon Ca2+ influx through NMDA receptor753.3×1e-08
Assembly and cell surface presentation of NMDA receptors827.1×5e-08
Neurexins and neuroligins923.6×2e-08
Negative regulation of MAPK pathway517.7×2e-04
Protein-protein interactions at synapses517.7×2e-04
RAF/MAP kinase cascade86.5×5e-04

GO biological processes:

GO termPartnersFoldFDR
establishment or maintenance of epithelial cell apical/basal polarity946.7×1e-10
protein localization to synapse534.2×3e-05
receptor clustering633.4×4e-06
regulation of postsynaptic membrane neurotransmitter receptor levels522.1×2e-04
protein-containing complex assembly99.2×6e-05
cell-cell adhesion109.1×2e-05
chemical synaptic transmission85.5×4e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

42 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance29
Likely benign2
Benign3

Top pathogenic / likely-pathogenic (0)

SpliceAI

0 predictions. Top by Δscore:

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000005874 (17:44800041 G>A), RS1000037102 (17:44799699 G>T), RS1000167992 (17:44794564 C>T), RS1000176499 (17:44810933 A>G), RS1000228381 (17:44808699 T>C), RS1000330347 (17:44830230 C>A,G,T), RS1000424341 (17:44822922 T>C), RS1000564811 (17:44823172 G>A), RS1000654662 (17:44819515 G>A,C,T), RS1000845493 (17:44804982 A>G), RS1000935713 (17:44831560 G>C), RS1000945602 (17:44798310 G>A,T), RS1000957944 (17:44819293 C>T), RS1000994921 (17:44798576 T>C), RS1001233165 (17:44825719 G>A)

Disease associations

OMIM: gene MIM:608655 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: other ic — Connexins and Pannexins

CTD chemical–gene interactions

59 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Aciddecreases methylation, affects cotreatment, decreases expression, affects expression6
Benzo(a)pyreneaffects methylation, decreases expression, decreases methylation2
Nickeldecreases expression2
Phenylmercuric Acetatedecreases expression, affects cotreatment2
Particulate Matterdecreases expression, increases abundance2
methylmercuric chloridedecreases expression1
bisphenol Adecreases expression1
terbufosdecreases methylation1
2,4,5,2’,4’,5’-hexachlorobiphenylaffects expression1
beta-lapachonedecreases expression1
zinc chromatedecreases expression, increases abundance1
dibenzo(a,l)pyrenedecreases expression1
beta-methylcholineaffects expression1
fumonisin B1decreases expression1
chromium hexavalent iondecreases expression, increases abundance1
CGP 52608affects binding, increases reaction1
chloropicrinincreases expression1
2-palmitoylglycerolincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
erucylphospho-N,N,N-trimethylpropylammoniumincreases expression1
ICG 001increases expression1
abrineincreases expression1
dorsomorphindecreases expression, affects cotreatment1
SRM 1597decreases expression1
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidinedecreases expression, increases response to substance1
jinfukangaffects cotreatment, decreases expression1
NSC 689534affects binding, decreases expression1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acidincreases expression1
Sunitinibdecreases expression1
Vorinostatdecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.